newsfilter
← Latest News
GlobeNewswire·

CV Sciences, Inc. Announces Launch of +PlusCBD™ Pain Relief Topicals

SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol ("CBD") products, today announced the launch of +PlusCBD™ Pai